share_log

Marker Therapeutics Shares Are Trading Higher After the Company Announced It Won a $9.5 Million Grant to Study Pancreatic Cancer Therapy.

Marker Therapeutics Shares Are Trading Higher After the Company Announced It Won a $9.5 Million Grant to Study Pancreatic Cancer Therapy.

Marker Therapeutics的股票在公司宣佈贏得了950萬美元的贈款用於研究胰腺癌療法後,交易價格上漲。
Benzinga ·  12/17 21:35

Marker Therapeutics Shares Are Trading Higher After the Company Announced It Won a $9.5 Million Grant to Study Pancreatic Cancer Therapy.

Marker Therapeutics的股票在公司宣佈贏得了950萬美元的贈款用於研究胰腺癌療法後,交易價格上漲。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論